Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illinois Tool Works
ITW
|
+$224M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$199M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$129M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$116M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$1.15B |
| 3 |
NVIDIA
NVDA
|
+$628M |
| 4 |
Amazon
AMZN
|
+$524M |
| 5 |
Tesla
TSLA
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 11.58% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CytomX Therapeutics
CTMX
$675M
| $292K | ﹤0.01% |
134,118
-1,184
| -0.9% | -$2.19K |
|
3752
Nuveen Municipal Credit Income Fund
NZF
$2.4B
| $291K | ﹤0.01% |
23,810
| – | – |
|
3753
Hawthorn Bancshares
HWBK
$269M
| $290K | ﹤0.01% |
14,204
-59
| -0.4% | -$1.34K |
|
3754
Turkcell
TKC
$4.68B
| $290K | ﹤0.01% |
55,811
+7,565
| +16% | +$39.7K |
|
3755
Annovis Bio
ANVS
$74.4M
| $289K | ﹤0.01% |
24,267
-4,781
| -16% | -$52.2K |
|
3756
Saga Communications
SGA
$57M
| $288K | ﹤0.01% |
12,897
-9
| -0.1% | -$208 |
|
3757
MoonLake Immunotherapeutics
MLTX
$1.57B
| $287K | ﹤0.01% |
5,714
-1,488
| -21% | -$80.7K |
|
|
ALIM
3758
DELISTED
Alimera Sciences
ALIM
| $286K | ﹤0.01% |
73,418
+59,286
| +420% | +$226K |
|
3759
FTC Solar
FTCI
$44M
| $286K | ﹤0.01% |
53,000
-1,891
| -3% | -$10.2K |
|
3760
Goldman Sachs BDC
GSBD
$969M
| $285K | ﹤0.01% |
19,001
+537
| +3% | +$8.12K |
|
3761
BGSF Inc
BGSF
$59.5M
| $284K | ﹤0.01% |
27,289
-1,737
| -6% | -$17.3K |
|
3762
Arm
ARM
$256B
| $283K | ﹤0.01% |
2,266
-71,877
| -97% | -$7.62M |
|
3763
Canterbury Park Holding Corp
CPHC
$78.8M
| $281K | ﹤0.01% |
12,051
-671
| -5% | -$15.4K |
|
3764
First Northwest Bancorp
FNWB
$109M
| $281K | ﹤0.01% |
17,927
-168
| -0.9% | -$2.51K |
|
3765
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
| $279K | ﹤0.01% |
1,983
-4,392
| -69% | -$589K |
|
|
PRPH
3766
DELISTED
ProPhase Labs
PRPH
| $278K | ﹤0.01% |
4,300
-296
| -6% | -$15K |
|
3767
Ohio Valley Banc Corp
OVBC
$198M
| $278K | ﹤0.01% |
11,367
-69
| -0.6% | -$1.66K |
|
3768
Zevia
ZVIA
$122M
| $278K | ﹤0.01% |
237,445
-12,026
| -5% | -$18.5K |
|
|
ASAI
3769
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $278K | ﹤0.01% |
18,788
-1,363
| -7% | -$19.3K |
|
3770
YPF
YPF
$206B
| $278K | ﹤0.01% |
14,023
+225
| +2% | +$3.91K |
|
3771
TriSalus Life Sciences
TLSI
$279M
| $277K | ﹤0.01% |
28,423
+10,233
| +56% | +$94.5K |
|
|
CALB
3772
DELISTED
California BanCorp Common Stock
CALB
| $277K | ﹤0.01% |
12,586
-74
| -0.6% | -$1.74K |
|
3773
VanEck Pharmaceutical ETF
PPH
$959M
| $276K | ﹤0.01% |
+3,048
| New | +$267K |
|
3774
Invesco Dorsey Wright Momentum ETF
PDP
$1.46B
| $276K | ﹤0.01% |
2,798
| – | – |
|
3775
American Outdoor Brands
AOUT
$155M
| $276K | ﹤0.01% |
31,338
-152
| -0.5% | -$1.31K |
|
Similar funds
Northern Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Northern Trust held 4,565 positions worth $579B, up 4.8% from $552B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Northern Trust withdrew a net $22.5B in Q1 2024, closing 140 positions and reducing 3,160 holdings. Its most notable exit was Splunk Inc, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Northern Trust opened a new position in Arcadium Lithium plc worth $50.1M.
- Northern Trust's largest Q1 2024 buy was Arcadium Lithium plc: 11,618,079 shares worth $50.1M.
- Northern Trust added most to Illinois Tool Works in Q1 2024, an estimated $224M increase.
- Northern Trust's biggest Q1 2024 reduction was Apple, cutting an estimated $1.44B.
- Northern Trust fully exited Splunk Inc in Q1 2024, selling an estimated $163M.
- Northern Trust's ten largest holdings make up 25% of its $579B portfolio in Q1 2024.
- Northern Trust opened 95 new positions and closed 140 in Q1 2024.
- Northern Trust's portfolio value rose 4.8% quarter-over-quarter to $579B.
Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.